Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3027318	s-etglygc	— (—)	90	97	100.00%	Distribution not available
3027318	s-etglygc	mmol/l (mmol/l)	36	37	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

64.81

154.84

1.1

1.0

—

mmol/l

—

69.15

154.49

1.1

1.0

—

mmol/l

—

Alcohol use disorder, Swedish definition

57.77

145.59

1.1

1.0

—

mmol/l

—

Substance abuse

44.62

144.60

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to psychoactive substance use

44.48

144.44

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to alcohol

48.76

143.42

1.1

1.0

—

mmol/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

49.92

137.93

1.2

1.0

—

mmol/l

—

Substance abuse, excluding more controls

51.27

137.05

1.1

1.0

—

mmol/l

—

Alcohol use disorder, ICD-based

52.18

136.23

1.2

1.0

—

mmol/l

—

Alcohol dependence

54.22

94.80

1.2

1.0

—

mmol/l

—

Acute alcohol intoxication, ICD10

40.19

78.83

1.2

1.0

—

mmol/l

—

Persons encountering health services in other circumstances

24.02

74.07

1.2

1.0

—

mmol/l

—

Poisoning by medicine

32.99

71.62

1.2

1.1

—

mmol/l

—

Poisoning by drugs, medicaments and biological substances

30.78

70.14

1.2

1.1

—

mmol/l

—

Suicide or other Intentional self-harm

22.29

54.39

1.3

1.0

—

mmol/l

—

Other disorders of fluid, electrolyte and acid-base balance

21.10

54.07

1.2

1.1

—

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

19.57

52.82

1.2

1.0

—

mmol/l

—

Mood disorders, excluding more controls

20.38

52.74

1.1

1.0

—

mmol/l

—

Acute alcohol intoxication

63.96

44.13

1.2

1.0

—

mmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

10.24

43.13

1.2

1.1

—

mmol/l

—

Benzodiazepine use

8.58

43.10

1.1

—

mmol/l

—

Implicit Sepsis

9.93

42.42

1.1

—

mmol/l

—

Any mental disorder

14.77

39.83

1.2

1.0

—

mmol/l

—

Implicit Sepsis

9.52

39.08

1.2

1.1

—

mmol/l

—

Condition for Implicit Sepsis (Organ dysfunction codes)

8.89

38.87

1.2

1.0

—

mmol/l

—

Mood [affective] disorders

7.58

35.89

1.1

—

mmol/l

—

Mood disorders

7.57

35.81

1.1

—

mmol/l

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

51.15

34.32

1.2

1.0

—

mmol/l

—

Depression

7.73

34.27

1.2

1.1

—

mmol/l

—

Exposure to unspecified factor

6.97

34.25

1.1

—

mmol/l

—

Implicit bacterial Sepsis

11.85

33.71

1.1

—

mmol/l

—

Implicit bacterial Sepsis

13.12

33.32

1.1

—

mmol/l

—

Open wound of head

9.41

33.19

1.2

1.0

—

mmol/l

—

Bacterial Sepsis

11.41

31.87

1.1

—

mmol/l

—

Disorders of adult personality and behaviour

11.88

31.61

1.2

1.1

—

mmol/l

—

Personality disorders

12.43

31.48

1.2

1.1

—

mmol/l

—

Alcohol abuse, main dg

39.24

31.14

1.2

1.0

—

mmol/l

—

Other antidepressants

9.23

31.11

1.1

—

mmol/l

—

Psychiatric diseases

13.78

30.46

1.2

1.0

—

mmol/l

—

Concussion

11.43

30.24

1.2

1.1

—

mmol/l

—

Intracranial trauma

10.98

30.17

1.2

1.1

—

mmol/l

—

Substance use, excluding alcohol

56.85

29.09

1.1

1.0

—

mmol/l

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

31.81

29.00

1.3

1.0

—

mmol/l

—

Selective serotonin reuptake inhibitors

8.59

28.48

1.1

—

mmol/l

—

Intracranial injury

7.82

27.10

1.2

1.0

—

mmol/l

—

Anxiety disorders, excluding more controls

13.42

27.02

1.2

1.0

—

mmol/l

—

Injuries to the head

5.94

26.35

1.2

1.0

—

mmol/l

—

Fall on same level

6.08

26.23

1.2

1.1

—

mmol/l

—

Personality disorders, excluding more controls

34.51

24.22

1.2

1.0

—

mmol/l

—

Persons encountering health services in other circumstances, wide

6.01

23.93

1.2

1.0

—

mmol/l

—

Depression or dysthymia

16.01

22.84

1.1

1.0

—

mmol/l

—

Schizophrenia or delusion, excluding more controls

35.95

22.83

1.1

1.0

—

mmol/l

—

Renal failure

8.09

22.74

1.0

1.3

—

mmol/l

—

Schizophrenia or delusion

8.54

22.74

1.1

1.2

—

mmol/l

—

Schizophrenia, schizotypal and delusional disorders

8.54

22.74

1.1

1.2

—

mmol/l

—

Falls/tendency to fall

6.63

22.36

1.1

—

mmol/l

—

Invasive ventilation

52.42

22.09

1.0

—

mmol/l

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

9.01

22.05

1.3

1.1

—

mmol/l

—

Use of hypnotics and sedatives

5.33

21.11

1.2

1.0

—

mmol/l

—

Malaise and fatigue

7.57

20.01

1.1

1.0

—

mmol/l

—

Acute renal failure

19.39

19.45

1.0

1.3

—

mmol/l

—

Renal tubulo-interstitial diseases

5.25

19.29

1.0

1.2

—

mmol/l

—

Other anxiety disorders

7.59

18.75

1.3

1.0

—

mmol/l

—

Specific personality disorders

15.03

18.38

1.2

—

mmol/l

—

Anxiety (asthma-related co-morbidities)

17.86

18.34

1.3

1.0

—

mmol/l

—

Unspecified mental disorder

6.67

17.81

1.1

1.2

—

mmol/l

—

Use of disulfiram, acamprosate or naltrexone

28.91

17.40

1.2

1.0

—

mmol/l

—

Pneumonia, organism unspecified

4.75

17.33

1.1

—

mmol/l

—

Emotionally unstable personality disorder

31.54

17.01

1.2

1.1

—

mmol/l

—

Metabolic disorders

4.95

16.73

1.2

1.1

—

mmol/l

—

All kidney diseases

4.52

16.64

1.1

—

mmol/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

40.29

16.32

1.2

1.0

—

mmol/l

—

Kela-code for severe mental illness

6.76

16.11

1.1

1.2

—

mmol/l

—

Alcohol withdrawal state with delirium

30.21

16.10

1.2

1.0

—

mmol/l

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.32

15.78

1.1

—

mmol/l

—

Pneumonias (Asthma/COPD co-morbidities)

4.26

15.41

1.1

—

mmol/l

—

All pneumoniae

4.24

15.30

1.1

—

mmol/l

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4.92

15.05

1.1

—

mmol/l

—

4.92

15.05

1.1

—

mmol/l

—

Bleeding

4.70

14.54

1.1

—

mmol/l

—

Diseases of liver

6.32

14.53

1.0

1.2

—

mmol/l

—

Influenza and pneumonia

4.09

14.40

1.1

—

mmol/l

—

Other bacterial diseases

4.18

13.76

1.1

—

mmol/l

—

Volume depletion

34.12

13.49

1.0

—

mmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

21.18

13.31

1.4

1.0

—

mmol/l

—

All anxiety disorders

5.05

13.27

1.3

1.0

—

mmol/l

—

Other symptoms and signs involving cognitive functions and awareness

5.82

12.42

1.2

1.1

—

mmol/l

—

Other bacterial diseases

3.77

11.89

1.1

—

mmol/l

—

Hypo-osmolality and hyponatraemia

16.31

11.60

1.2

1.0

—

mmol/l

—

Recurrent or chronic depression

21.10

11.48

1.0

—

mmol/l

—

Neurotic, stress-related and somatoform disorders

3.81

11.26

1.2

1.0

—

mmol/l

—

Any death

4.62

11.25

1.0

1.2

—

mmol/l

—

Anxiety disorders

3.68

10.77

1.2

1.0

—

mmol/l

—

Other and unspecified myopathies

28.10

10.72

1.1

1.0

—

mmol/l

—

Other specified and unspecified personality disorders

21.50

10.67

1.2

1.1

—

mmol/l

—

General symptoms and signs

3.89

10.47

1.2

1.0

—

mmol/l

—

Other external causes of accidental injury

6.40

10.31

1.3

1.0

—

mmol/l

—

Accidents

6.40

10.31

1.3

1.0

—

mmol/l

—

Symptoms and signs involving the nervous and musculoskeletal systems

4.19

10.06

1.1

—

mmol/l

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.50

10.00

1.2

1.0

—

mmol/l

—

Bacterial infection, other or unspecified

4.77

9.52

1.0

1.1

—

mmol/l

—

Diseases of the myoneural junction and muscle

13.67

9.16

1.1

1.0

—

mmol/l

—

Hypokalaemia

13.67

9.16

1.1

—

mmol/l

—

Chronic apical periodontitis

3.20

9.16

1.2

1.1

—

mmol/l

—

Alcoholic liver disease

18.62

8.92

1.0

1.3

—

mmol/l

—

Delirium, not induced by alcohol and other psychoactive substances

18.57

8.91

1.2

1.0

—

mmol/l

—

Type of accident

7.42

8.90

1.3

1.1

—

mmol/l

—

Diabetes mellitus

3.33

8.85

1.2

1.1

—

mmol/l

—

Bacterial infection, other or unspecified

4.32

8.80

1.0

1.1

—

mmol/l

—

Convulsions, not elsewhere classified

8.47

8.69

1.1

1.0

—

mmol/l

—

Pneumonitis due to solids and liquids

16.31

8.54

1.2

1.0

—

mmol/l

—

Non-selective monoamine reuptake inhibitors

9.11

8.53

1.1

1.2

—

mmol/l

—

Other and unspecified effects of external causes

6.90

8.52

1.1

1.2

—

mmol/l

—

Acute pancreatitis

8.96

8.51

1.2

—

mmol/l

—

Lung diseases due to external agents

12.75

8.36

1.2

—

mmol/l

—

Viral hepatitis, IBD co-morbidity

+∞

8.33

1.1

0.0

—

mmol/l

—

Nausea and vomiting

8.33

8.16

1.2

—

mmol/l

—

Diabetes, varying definitions

3.20

8.15

1.2

1.1

—

mmol/l

—

Unspecified fall

3.91

8.12

1.1

—

mmol/l

—

Event of undetermined intent

17.21

8.07

1.1

1.0

—

mmol/l

—

Other and unspecified nonorganic psychotic disorders

8.11

8.06

1.0

1.2

—

mmol/l

—

Diseases of pulp and periapical tissues, including avohilmo

3.39

8.01

1.1

—

mmol/l

—

Behavioural syndromes associated with physiological disturbances and physical factors

3.13

7.93

1.1

—

mmol/l

—

Insulin medication

3.81

7.83

1.2

1.1

—

mmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

10.79

7.78

1.1

1.3

—

mmol/l

—

Epilepsy

6.32

7.67

1.0

1.2

—

mmol/l

—

Acute pancreatitis (for exclusion)

7.40

7.65

1.2

1.1

—

mmol/l

—

Fever of other and unknown origin

4.24

7.62

1.2

1.0

—

mmol/l

—

Endocrine, nutritional and metabolic diseases

3.80

7.35

1.1

—

mmol/l

—

Parasetamol

3.88

7.25

1.2

1.0

—

mmol/l

—

Infections of the skin and subcutaneous tissue

3.30

7.23

1.2

1.1

—

mmol/l

—

Antihypertensive medication - note that there are other indications

4.82

7.22

1.1

—

mmol/l

—

Erysipelas

3.53

7.17

1.2

1.1

—

mmol/l

—

Explicit Sepsis

6.23

7.15

1.1

—

mmol/l

—

Alcohol-induced chronic pancreatitis

20.07

7.13

1.3

1.0

—

mmol/l

—

Other reaction to severe stress, and adjustment disorders

6.54

7.09

1.2

1.0

—

mmol/l

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3.48

7.09

1.2

1.1

—

mmol/l

—

All chronic kidney diseases

4.20

6.97

1.0

1.2

—

mmol/l

—

Diseases of the digestive system

4.17

6.94

1.2

1.1

—

mmol/l

—

Insulin, intermediate and long-acting

3.56

6.83

1.2

1.1

—

mmol/l

—

Leisure time condition

8.25

6.81

1.4

1.2

—

mmol/l

—

Bipolar affective disorders

9.30

6.77

1.3

1.1

—

mmol/l

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3.28

6.70

1.1

1.0

—

mmol/l

—

Hypertensive diseases (excluding secondary)

4.30

6.68

1.2

1.3

—

mmol/l

—

Certain infectious and parasitic diseases

3.27

6.67

1.2

1.0

—

mmol/l

—

Dental pulpitis, including avohilmo

2.83

6.59

1.2

1.1

—

mmol/l

—

Traumatic subdural haemorrhage

16.01

6.58

1.1

1.3

—

mmol/l

—

Chronic pancreatitis

12.24

6.57

1.3

1.2

—

mmol/l

—

Persons encountering health services for specific procedures and health care

2.77

6.56

1.1

—

mmol/l

—

Other septicaemia

5.84

6.53

1.1

—

mmol/l

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3.01

6.52

1.2

1.1

—

mmol/l

—

Type 2 diabetes, wide definition

3.33

6.49

1.2

1.0

—

mmol/l

—

Organic, including symptomatic, mental disorders

4.10

6.47

1.2

1.1

—

mmol/l

—

Erysipelas

3.82

6.35

1.2

1.1

—

mmol/l

—

severe traumatic brain injury, does not include concussion

6.53

6.32

1.1

1.2

—

mmol/l

—

COPD/asthma related infections

3.13

6.29

1.2

1.1

—

mmol/l

—

COPD/asthma/ILD related infections

3.13

6.29

1.2

1.1

—

mmol/l

—

Septicaemia

5.10

6.19

1.1

1.2

—

mmol/l

—

Injuries to the wrist and hand

2.72

6.10

1.1

—

mmol/l

—

Injuries to the thorax

3.58

6.02

1.3

1.1

—

mmol/l

—

Sleep disorders

2.87

5.97

1.1

—

mmol/l

—

Cardiovascular diseases (excluding rheumatic etc)

3.48

5.91

1.2

—

mmol/l

—

External causes of morbidity and mortality

6.68

5.86

1.2

1.0

—

mmol/l

—

Other disorders of urethra and urinary system

3.38

5.85

1.1

—

mmol/l

—

Cutaneous abscess, furuncle and carbuncle

5.77

5.82

1.1

1.2

—

mmol/l

—

Persistent mood disorders

9.18

5.78

1.1

—

mmol/l

—

Neurological diseases, wide definition

9.33

5.75

1.2

1.0

—

mmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.89

5.74

1.2

1.1

—

mmol/l

—

Insulin, fast-acting

3.90

5.70

1.1

—

mmol/l

—

Assault

7.51

5.62

1.0

1.3

—

mmol/l

—

Intestinal infectious diseases

2.64

5.59

1.2

1.1

—

mmol/l

—

Heart failure and antihypertensive medication

13.09

5.57

1.0

1.2

—

mmol/l

—

Heart failure, not strict

3.03

5.55

1.1

1.2

—

mmol/l

—

Type 2 diabetes

2.78

5.52

1.2

1.1

—

mmol/l

—

Disorders of gallbladder, biliary tract and pancreas

2.74

5.50

1.1

—

mmol/l

—

Other symptoms and signs involving the nervous and musculoskeletal systems

4.60

5.46

1.2

—

mmol/l

—

Diabetes, insulin treatment (Kela reimbursement)

2.65

5.45

1.2

1.1

—

mmol/l

—

Mixed and other personality disorders

16.04

5.41

1.4

1.2

—

mmol/l

—

Ill-defined and unknown causes of mortality

16.04

5.41

1.0

—

mmol/l

—

Fracture of femur

5.77

5.39

1.2

1.1

—

mmol/l

—

Nutritional anaemias

3.76

5.38

1.1

1.2

—

mmol/l

—

Cardiovascular diseases

3.53

5.38

1.1

1.2

—

mmol/l

—

Diabetes medication

2.64

5.38

1.2

1.1

—

mmol/l

—

Fracture at wrist and hand level

3.72

5.34

1.1

—

mmol/l

—

STROKE

3.85

5.31

1.1

—

mmol/l

—

Nonorganic sleeping disorders, excluding more controls

11.26

5.28

1.1

1.0

—

mmol/l

—

Aplastic and other anaemias

3.73

5.27

1.1

1.2

—

mmol/l

—

Other diseases of the digestive system

5.00

5.24

1.3

1.1

—

mmol/l

—

GI-bleeding

5.00

5.24

1.3

1.1

—

mmol/l

—

Neurological diseases

2.95

5.22

1.1

—

mmol/l

—

Toxic effect of other and unspecified substances

+∞

5.21

1.4

0.0

—

mmol/l

—

Hypertension, essential

3.09

5.19

1.2

—

mmol/l

—

Atrial fibrillation and flutter with reimbursement

8.75

5.12

1.0

1.4

—

mmol/l

—

Chronic viral hepatitis

13.37

5.08

1.1

1.0

—

mmol/l

—

Exposure to other specified factors

2.68

5.06

1.0

1.1

—

mmol/l

—

Other and unspecified anaemias

3.76

5.04

1.1

1.2

—

mmol/l

—

Other anaemias

3.75

5.02

1.1

1.2

—

mmol/l

—

Genitourinary diseases

3.40

5.00

1.0

1.1

—

mmol/l

—

Asthma, unspecified (mode)

3.90

4.92

1.0

1.2

—

mmol/l

—

Type 1 diabetes

5.41

4.90

1.2

1.0

—

mmol/l

—

Insulin, fast-acting or short human

3.48

4.88

1.1

—

mmol/l

—

Pain in throat and chest

2.70

4.80

1.2

1.1

—

mmol/l

—

Excluding asthma or asthma-COPD overlap

3.29

4.78

1.1

1.2

—

mmol/l

—

Other viral hepatitis

11.46

4.78

1.1

—

mmol/l

—

Transport accidents

6.76

4.76

1.1

1.0

—

mmol/l

—

Insomnia

2.59

4.68

1.1

—

mmol/l

—

Diagnoses used for exclusion with ILD

4.67

1.2

—

mmol/l

—

Codeine

2.55

4.65

1.2

1.1

—

mmol/l

—

Any reimbursement code in KELA

3.61

4.65

1.1

1.0

—

mmol/l

—

Decubitus ulcer and pressure area

14.03

4.57

1.0

—

mmol/l

—

Maltreatment syndromes

10.03

4.52

1.1

—

mmol/l

—

Viral hepatitis

10.02

4.52

1.1

—

mmol/l

—

Open wound of forearm

10.02

4.52

1.0

—

mmol/l

—

Duodenal ulcer

10.01

4.51

1.4

1.0

—

mmol/l

—

Cystitis

2.85

4.48

1.2

1.1

—

mmol/l

—

Asthma, unspecified (mode), excluding more controls

4.32

4.44

1.0

1.2

—

mmol/l

—

Headache

3.13

4.43

1.1

1.0

—

mmol/l

—

Sleep disorders (combined)

2.43

4.35

1.1

—

mmol/l

—

Hard cardiovascular diseases

2.66

4.34

1.2

1.1

—

mmol/l

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4.59

4.31

1.0

1.3

—

mmol/l

—

Implicit viral Sepsis

6.25

4.28

1.1

—

mmol/l

—

Disorders of mineral metabolism

11.69

4.27

1.1

1.0

—

mmol/l

—

Sequelae of injuries of upper limb

11.68

4.27

1.0

—

mmol/l

—

Other pulmonary diagnosis

3.13

4.27

1.2

—

mmol/l

—

Certain infectious and parasitic diseases

3.13

4.27

1.4

1.0

—

mmol/l

—

Cerebrovascular diseases (FINNGEN)

5.31

4.24

1.1

1.3

—

mmol/l

—

Disorders of psychological development

6.19

4.20

1.0

—

Fall on and from stairs and steps

4.80

4.17

1.2

—

mmol/l

—

Schizophrenia

5.24

4.13

1.2

—

mmol/l

—

Other nutritional deficiencies

2.67

4.13

1.1

—

mmol/l

—

Injuries to the hip and thigh

3.15

4.13

1.2

1.1

—

mmol/l

—

Other heart diseases

3.50

4.10

1.0

1.2

—

mmol/l

—

Gastrointestinal diseases

3.41

4.09

1.2

1.0

—

mmol/l

—

Fracture of lower leg, including ankle

2.77

4.03

1.2

1.1

—

mmol/l

—

Injury, poisoning and certain other consequences of external causes

5.47

4.01

1.2

1.0

—

mmol/l

—

Schizoaffective disorder

10.02

4.01

1.0

1.1

—

mmol/l

—

Other diseases of urinary system

2.42

4.01

1.2

1.1

—

mmol/l

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3.03

3.99

1.1

—

mmol/l

—

Care involving use of rehabilitation procedures

2.77

3.98

1.1

—

mmol/l

—

Implicit viral Sepsis

6.43

3.98

1.1

—

mmol/l

—

Viral Sepsis

6.43

3.98

1.1

—

mmol/l

—

Secondary hypertension

9.89

3.98

1.0

1.4

—

mmol/l

—

Exclusions for E4_PCOS_CONSORTIUM

2.85

3.98

1.2

1.1

—

mmol/l

—

Bronchitis

2.28

3.90

1.1

—

mmol/l

—

Type 2 diabetes, definitions combined, including avohilmo

2.51

3.89

1.2

1.1

—

mmol/l

—

Hypertensive diseases

2.70

3.88

1.2

—

mmol/l

—

Hypertension

2.70

3.87

1.2

—

mmol/l

—

Dialysis, with operation codes

7.28

3.85

1.0

1.4

—

mmol/l

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.30

3.81

1.1

—

mmol/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

4.29

3.81

1.0

1.3

—

mmol/l

—

Acute tubulo-interstitial nephritis

3.00

3.79

1.1

1.2

—

mmol/l

—

Diseases of the skin and subcutaneous tissue

2.35

3.78

1.1

—

mmol/l

—

COPD differential diagnosis

2.97

3.78

1.2

—

mmol/l

—

ILD differential diagnosis

2.97

3.78

1.2

—

mmol/l

—

Other disorders of glucose regulation and pancreatic internal secretion

8.76

3.77

1.0

—

mmol/l

—

Unspecified kidney failure

12.01

3.76

1.0

1.4

—

mmol/l

—

Symptoms and signs involving the digestive system and abdomen

2.42

3.74

1.2

1.1

—

mmol/l

—

Episodal and paroxysmal disorders

2.25

3.73

1.1

—

mmol/l

—

Injuries to the elbow and forearm

2.48

3.71

1.0

1.1

—

mmol/l

—

Persons with potential health hazards related to communicable diseases

3.15

3.71

1.4

1.1

—

mmol/l

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

3.15

3.70

1.1

—

mmol/l

—

Fracture of rib(s), sternum and thoracic spine

3.83

3.68

1.3

1.1

—

mmol/l

—

Medical abortion

3.21

3.67

1.1

—

mmol/l

—

Asthma

2.95

3.60

1.0

1.2

—

mmol/l

—

Asthma, excluding more controls

3.06

3.58

1.0

1.2

—

mmol/l

—

Gout, idiopatic and unspecified

4.77

3.55

1.1

1.2

—

mmol/l

—

Heart failure,strict

2.97

3.55

1.0

1.2

—

mmol/l

—

Type 2 diabetes, definitions combined

2.43

3.53

1.2

1.1

—

mmol/l

—

Obesity due to excess calories

2.81

3.51

1.1

1.2

—

mmol/l

—

Superficial injury of abdomen, lower back and pelvis

6.16

3.50

1.1

1.2

—

mmol/l

—

Codeine or tramadol medication

2.14

3.49

1.2

1.1

—

mmol/l

—

Gout, FINNGEN

4.22

3.49

1.3

1.1

—

mmol/l

—

Chronic kidney disease

4.67

3.48

1.0

1.2

—

mmol/l

—

Cellulitis

4.55

3.42

1.2

—

mmol/l

—

Type 2 diabetes, strict (exclude DM1)

2.39

3.42

1.2

1.1

—

mmol/l

—

Symptoms and signs involving the circulatory and respiratory systems

2.26

3.41

1.3

1.1

—

mmol/l

—

Other diseases of liver

5.00

3.36

1.0

1.4

—

mmol/l

—

Gout, unspecified

5.00

3.36

1.1

—

mmol/l

—

Abnormal involuntary movements

7.01

3.36

1.3

1.0

—

Syncope and collapse

3.48

3.29

1.2

1.0

—

mmol/l

—

Heart failure, strict

2.73

3.27

1.0

1.2

—

mmol/l

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.15

3.26

1.2

1.1

—

mmol/l

—

Undetermined asthma

8.57

3.26

1.0

1.3

—

mmol/l

—

Tramadol

2.36

3.24

1.2

1.1

—

mmol/l

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.02

3.23

1.1

1.0

—

mmol/l

—

Nonorganic sleeping disorders

4.74

3.23

1.1

1.2

—

mmol/l

—

Hyperlipidaemia, other/unspecified

3.89

3.22

1.1

—

mmol/l

—

Gout, strict definition

5.34

3.19

1.1

—

mmol/l

—

Gout

3.87

3.18

1.3

1.2

—

mmol/l

—

Other (not insulin) diabetes medications

2.25

3.16

1.1

—

mmol/l

—

Heart failure and bmi 25plus

3.68

3.13

1.0

1.3

—

mmol/l

—

Abnormalities of heart beat

3.72

3.11

1.1

—

mmol/l

—

Disorders of lipoprotein metabolism and other lipidaemias

2.59

3.07

1.1

—

mmol/l

—

Assault by bodily force

7.51

3.05

1.0

1.1

—

mmol/l

—

Hypoglycaemia, other or unspecified

7.51

3.05

1.0

—

Superficial injury of head

5.00

3.04

1.4

1.1

—

mmol/l

—

Early onset COPD, excluding more controls

5.00

3.04

1.0

1.3

—

mmol/l

—

Nephropathy related operations

5.84

3.02

1.0

1.2

—

mmol/l

—

Acute and transient psychotic disorders

5.84

3.02

1.1

1.3

—

mmol/l

—

Injuries to the knee and lower leg

2.02

3.02

1.1

—

mmol/l

—

Abdominal and pelvic pain

2.24

3.01

1.2

1.1

—

mmol/l

—

Other heart diseases, wide

2.15

3.00

1.1

—

mmol/l

—

Sub-endpoint used in defining T1D endpoints

3.28

2.95

1.2

1.1

—

mmol/l

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.12

2.94

1.1

—

mmol/l

—

Injuries to the ankle and foot

2.25

2.93

1.0

1.1

—

mmol/l

—

Dysphagia

4.71

2.91

1.1

1.2

—

mmol/l

—

Factors influencing health status and contact with health services

5.74

2.91

1.0

—

mmol/l

—

All-cause Heart Failure

2.63

2.91

1.0

1.2

—

mmol/l

—

Spondyloarthritis

4.09

2.88

1.2

1.3

—

mmol/l

—

Other fall from one level to another

3.70

2.87

1.0

1.3

—

mmol/l

—

Undetermined asthma, excluding more controls

6.67

2.86

1.0

1.4

—

mmol/l

—

Phobic anxiety disorders

6.66

2.86

1.0

1.1

—

mmol/l

—

Iron deficiency anaemia

3.39

2.84

1.2

—

mmol/l

—

Open wound of wrist and hand

2.57

2.82

1.0

1.1

—

mmol/l

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.04

2.80

1.1

—

mmol/l

—

Biguanides

2.15

2.79

1.1

—

mmol/l

—

Asthma (mode)

2.68

2.79

1.0

1.2

—

mmol/l

—

Superficial injury of lower leg

3.91

2.77

1.0

1.3

—

mmol/l

—

GASTRO-related operations

2.39

2.77

1.2

1.0

—

mmol/l

—

Any gastric operation

2.39

2.77

1.2

1.0

—

mmol/l

—

General examination and investigation of persons without complaint and reported diagnosis

2.37

2.76

1.2

1.0

—

mmol/l

—

Intestinal infectious diseases

1.97

2.76

1.2

1.1

—

mmol/l

—

Pain (limb, back, neck, head abdominally)

2.39

2.76

1.3

1.1

—

mmol/l

—

Injury of other and unspecified intrathoracic organs

8.35

2.75

1.2

1.0

—

mmol/l

—

Other soft tissue disorders, not elsewhere classified

2.09

2.71

1.2

1.1

—

mmol/l

—

Intracerebral haemorrhage

6.00

2.69

1.0

1.2

—

mmol/l

—

Bacterial pneumoniae

3.02

2.67

1.0

1.2

—

mmol/l

—

Asthma (only as main-diagnosis), excluding more controls

2.76

2.63

1.0

1.2

—

mmol/l

—

Symptoms and signs involving the urinary system

2.21

2.62

1.1

—

mmol/l

—

Cardiac arrhythmias

2.82

2.62

1.2

1.1

—

mmol/l

—

Autoimmune diseases excluding thyroid diseases

1.98

2.61

1.1

—

mmol/l

—

Migraine without aura

4.67

2.59

1.0

1.2

—

Caries of dentine

3.65

2.59

1.1

—

Diseases of the respiratory system

2.81

2.59

1.1

—

mmol/l

—

Other noninfective gastroenteritis and colitis

3.60

2.57

1.0

1.3

—

mmol/l

—

Other diseases of the respiratory system

4.00

2.56

1.1

1.2

—

mmol/l

—

Other respiratory disorders and diseases

4.00

2.56

1.1

1.2

—

mmol/l

—

Smoking dependency

7.15

2.55

1.0

—

Eating disorder

7.14

2.54

1.4

1.1

—

Type 1 diabetes, strict (exclude DM2)

5.45

2.53

1.0

1.1

—

mmol/l

—

Type 1 diabetes, definitions combined

5.44

2.53

1.0

1.1

—

mmol/l

—

Haemorrhage from respiratory passages

3.22

2.47

1.1

—

mmol/l

—

Other and unspecified iron deficiency

3.46

2.47

1.0

1.2

—

mmol/l

—

Gastroduodenal ulcer

3.45

2.47

1.3

1.1

—

mmol/l

—

Dental caries

3.46

2.46

1.1

—

Retention of urine

3.01

2.45

1.2

1.3

—

mmol/l

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.48

2.45

1.1

1.0

—

Obesity

2.25

2.44

1.1

—

mmol/l

—

Autoimmune diseases

1.92

2.43

1.1

—

mmol/l

—

Oedema, not elsewhere classified

3.76

2.42

1.0

—

mmol/l

—

Infections, IBD-co-morbidities

7.14

2.38

1.0

—

mmol/l

—

Missing teeth due to accident, extraction or parodontitis

2.28

2.37

1.2

1.1

—

mmol/l

—

Elevated blood glucose level

6.26

2.37

1.4

1.1

—

mmol/l

—

Glomerulonephritis

6.26

2.37

1.2

1.0

—

mmol/l

—

Eating disorders

6.25

2.37

1.4

1.1

—

Obesity and other hyperalimentation

2.21

2.36

1.1

—

mmol/l

—

Periapical abscess

2.41

2.36

1.2

1.1

—

mmol/l

—

Presence of other functional implants

2.42

2.35

1.2

1.1

—

mmol/l

—

Other CVD (FINNGEN)

6.46

2.30

1.0

1.5

—

mmol/l

—

Asthma (only as main-diagnosis)

2.53

2.29

1.0

1.2

—

mmol/l

—

Panic disorder

5.56

2.21

1.0

1.1

—

Acetic acid derivatives and related substances

3.78

2.19

1.1

1.0

—

mmol/l

—

Paralytic ileus and intestinal obstruction

3.33

2.17

1.0

1.1

—

mmol/l

—

Superficial injury of thorax

4.29

2.15

1.2

1.0

—

mmol/l

—

Spondylopathies (FG)

3.69

2.15

1.3

—

mmol/l

—

Bacterial pneumonia (organism specified)

2.47

2.10

1.0

1.2

—

mmol/l

—

Suppurative and unspecified otitis media

2.47

2.09

1.1

1.2

—

mmol/l

—

Superficial injury of forearm

5.00

2.07

1.0

1.2

—

Covid-19 confirmed case

2.70

2.06

1.1

1.2

—

mmol/l

—

Coxibs

3.51

2.06

1.1

1.0

—

Non-ischemic cardiomyopathy

3.22

2.04

1.0

1.2

—

mmol/l

—

Hernia of abdominal wall

2.32

2.04

1.3

1.1

—

mmol/l

—

Diplopia

4.00

2.04

1.0

1.3

—

mmol/l

—

Other condition

4.00

2.04

1.0

1.3

—

mmol/l

—

Diseases of oesophagus, stomach and duodenum

1.83

2.03

1.2

1.1

—

mmol/l

—

Fracture of foot, except ankle

3.08

2.01

1.1

1.2

—

mmol/l

—

Gastro-oesophageal reflux disease

2.07

1.99

1.2

1.1

—

mmol/l

—

Contact with and exposure to communicable diseases

2.62

1.99

1.6

1.1

—

mmol/l

—

Other arthrosis

2.21

1.97

1.0

1.1

—

mmol/l

—

Nonalcoholic fatty liver disease

4.55

1.94

1.0

1.2

—

mmol/l

—

Abnormalities of gait and mobility

4.55

1.94

1.0

1.2

—

Bitten or struck by other mammals

4.55

1.94

1.0

1.2

—

mmol/l

—

Early onset COPD

2.96

1.93

1.0

1.3

—

mmol/l

—

Used for control exclusion in common control thyroid runs

1.79

1.92

1.1

—

mmol/l

—

Other acute lower respiratory infections

2.19

1.92

1.1

—

mmol/l

—

Fall on same level involving ice and snow

2.05

1.90

1.2

1.1

—

mmol/l

—

Other diseases of intestines

1.76

1.88

1.2

1.1

—

mmol/l

—

Speech and linguistic disorders

4.37

1.87

1.0

—

Constipation

1.89

1.87

1.1

—

mmol/l

—

Diseases of the eye and adnexa

1.90

1.85

1.2

1.1

—

mmol/l

—

Fracture of skull and facial bones

3.53

1.83

1.0

1.1

—

mmol/l

—

Other CVD

3.53

1.83

1.0

1.1

—

mmol/l

—

Acute upper respiratory infections of multiple and unspecified sites

1.93

1.83

1.1

—

mmol/l

—

Generalized anxiety disorder

4.17

1.82

1.2

1.1

—

Abnormal findings on examination of blood, without diagnosis

2.21

1.82

1.2

1.1

—

mmol/l

—

Other problems related to primary support group, including family circumstances

4.06

1.78

1.0

1.2

—

Congenital malformations of the circulatory system

4.04

1.77

1.0

1.1

—

mmol/l

—

COPD (mode)

3.06

1.75

1.0

1.3

—

mmol/l

—

Osteoporosis

2.97

1.74

1.0

1.2

—

mmol/l

—

Major coronary heart disease event excluding revascularizations

2.08

1.72

1.2

1.1

—

mmol/l

—

Diseases of middle ear and mastoid

2.04

1.72

1.1

—

mmol/l

—

Glomerular diseases

2.92

1.72

1.1

1.3

—

mmol/l

—

Insulin, fast-acting (human)

3.85

1.71

1.0

1.1

—

mmol/l

—

Complications of surgical and medical care, not elsewhere classified

1.77

1.70

1.0

1.1

—

mmol/l

—

Abnormalities of breathing

1.87

1.70

1.1

—

mmol/l

—

Statin medication

1.99

1.69

1.2

1.1

—

mmol/l

—

Atrial fibrillation and flutter

3.03

1.68

1.0

1.3

—

mmol/l

—

Myocardial infarction

2.18

1.68

1.2

1.1

—

mmol/l

—

Diseases of pulp and periapical tissues and dental caries

2.17

1.67

1.3

1.0

—

mmol/l

—

Acute bronchitis

2.51

1.66

1.1

1.2

—

mmol/l

—

Type 1 diabetes, wide definition, subgroup 1

3.16

1.66

1.0

—

mmol/l

—

Other viral diseases, not elsewhere classified

3.15

1.65

1.2

1.3

—

mmol/l

—

COPD, hospital admission 2, with asthma infections

2.54

1.60

1.0

1.2

—

mmol/l

—

Intestinal stricture

2.50

1.59

1.0

1.2

—

mmol/l

—

Pulmonary heart disease, diseases of pulmonary circulation

2.50

1.59

1.0

1.2

—

mmol/l

—

Acute and subacute iridocyclitis

3.00

1.58

1.2

—

mmol/l

—

Ganglion

3.00

1.58

1.0

1.3

—

Pain, not elsewhere classified

3.00

1.58

1.2

1.0

—

mmol/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

3.00

1.58

1.0

1.4

—

mmol/l

—

All influenza

2.69

1.58

1.1

1.2

—

mmol/l

—

Dental caries, including avohilmo

2.00

1.57

1.4

1.0

—

mmol/l

—

Other bacterial intestinal infections

3.33

1.52

1.0

1.1

—

mmol/l

—

Scabies

3.33

1.52

1.0

1.1

—

mmol/l

—

Hypotension

3.33

1.52

1.0

1.1

—

mmol/l

—

Stroke, excluding SAH

2.00

1.51

1.1

1.2

—

mmol/l

—

Sequelae of external causes of morbidity and mortality

2.59

1.51

1.3

—

mmol/l

—

Irritable bowel syndrome

2.59

1.51

1.1

—

mmol/l

—

Disorders of synovium and tendon

2.03

1.51

1.0

1.1

—

mmol/l

—

Anterior Iridocyclitis

2.86

1.50

1.2

1.3

—

mmol/l

—

Focal epilepsy

2.86

1.50

1.0

1.3

—

mmol/l

—

Hernia

1.71

1.49

1.2

1.1

—

mmol/l

—

Acute suppurative otitis media

2.47

1.49

1.1

—

mmol/l

—

Pain in limb

1.82

1.48

1.1

—

mmol/l

—

Necrosis of pulp, including avohilmo

1.89

1.48

1.1

—

mmol/l

—

Bacterial pneumonia, not elsewhere classified

2.40

1.46

1.0

1.2

—

mmol/l

—

Other or unspecified ileus, impaction or obstruction

3.12

1.43

1.0

1.1

—

mmol/l

—

Nontraumatic intracranial haemmorrhage

2.73

1.43

1.0

1.2

—

mmol/l

—

Abnormal serum enzyme levels

2.31

1.42

1.0

1.1

—

mmol/l

—

Stroke, including SAH

1.95

1.42

1.1

1.2

—

mmol/l

—

Spondylopathies

1.77

1.41

1.1

—

mmol/l

—

Finngen Rheumatological endpoints

1.68

1.41

1.2

1.1

—

mmol/l

—

Caries of dentine, including avohilmo

1.90

1.40

1.4

1.0

—

mmol/l

—

Injuries to the neck

2.41

1.39

1.0

1.2

—

mmol/l

—

Hypertensive heart and/or renal disease

3.11

1.38

1.0

1.2

—

mmol/l

—

Nasal polyp

2.61

1.36

1.0

1.3

—

mmol/l

—

Polyuria

2.61

1.36

1.3

—

mmol/l

—

Iridocyclitis

2.61

1.36

1.2

—

mmol/l

—

Type 1 diabetes, wide definition

2.61

1.36

1.0

—

mmol/l

—

Pediculosis, acariasis and other infestations

2.94

1.36

1.0

1.1

—

mmol/l

—

Cardiomyopathy

2.94

1.36

1.0

1.2

—

mmol/l

—

Migraine with aura

2.94

1.36

1.2

—

Polyarthropathies

1.83

1.34

1.2

1.1

—

mmol/l

—

COPD related to multimorbidity

2.17

1.34

1.0

1.2

—

mmol/l

—

Other headache syndromes

2.14

1.33

1.0

1.2

—

Polyarthrosis

2.90

1.33

1.0

1.1

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.12

1.32

1.0

1.1

—

Dermatitis and eczema

1.60

1.32

1.1

—

mmol/l

—

Other diseases of upper respiratory tract

1.59

1.31

1.0

1.1

—

mmol/l

—

Fibroblastic disorders

2.50

1.30

1.0

1.3

—

mmol/l

—

Functional dyspepsia

2.50

1.30

1.3

1.1

—

mmol/l

—

Myocardial infarction, without ST-elevation

2.10

1.30

1.0

1.2

—

Other functional intestinal disorders

2.11

1.29

1.2

1.0

—

mmol/l

—

Disorders of choroid and retina

1.73

1.29

1.0

1.1

—

mmol/l

—

Ischemic heart diseases

1.74

1.28

1.2

1.1

—

mmol/l

—

Diabetic retinopathy, excluding more controls

2.36

1.27

1.1

1.3

—

mmol/l

—

Cerebrovascular diseases

1.78

1.27

1.1

—

mmol/l

—

Other diseases of pleura

2.09

1.25

1.1

1.2

—

mmol/l

—

AV-block

2.74

1.25

1.0

1.1

—

mmol/l

—

Low back pain

1.70

1.23

1.1

—

mmol/l

—

Injuries to the shoulder and upper arm

1.66

1.23

1.3

1.1

—

mmol/l

—

Provisional assignment of new diseases of uncertain etiology

1.85

1.23

1.1

—

mmol/l

—

Opioids

1.65

1.22

1.2

1.1

—

mmol/l

—

Bacterial intestinal infections, IBD co-morbidities

2.63

1.21

1.0

1.2

—

mmol/l

—

Oxicams

2.84

1.21

1.2

1.0

—

mmol/l

—

Focal epilepsy, strict definition

2.63

1.21

1.0

1.3

—

mmol/l

—

Myocardial infarction, strict

2.01

1.21

1.0

1.1

—

mmol/l

—

Other abnormal products of conception

2.76

1.21

1.0

1.2

—

mmol/l

—

Other retinal disorders

1.82

1.20

1.0

1.2

—

mmol/l

—

Ventral hernia

2.31

1.18

1.7

1.2

—

mmol/l

—

Codes for special purposes

1.83

1.18

1.1

—

mmol/l

—

Asthma-related pneumonia

2.10

1.18

1.0

1.2

—

mmol/l

—

Asthma-related pneumonia or sepsis

2.10

1.18

1.0

1.2

—

mmol/l

—

Asthma, hospital admissions 3, pneumonia

2.10

1.18

1.0

1.2

—

mmol/l

—

Noninfective enteritis and colitis

1.87

1.17

1.0

1.2

—

mmol/l

—

Viral infections characterized by skin and mucous membrane lesions

2.00

1.16

1.0

1.1

—

mmol/l

—

Dizziness and giddiness

1.79

1.16

1.2

1.0

—

mmol/l

—

Superficial injury of wrist and hand

2.50

1.15

1.4

1.2

—

mmol/l

—

Other chronic obstructive pulmonary disease, including avohilmo

1.87

1.14

1.0

1.2

—

mmol/l

—

Soft tissue disorders

1.60

1.13

1.0

1.1

—

mmol/l

—

Fracture of shoulder and upper arm

2.00

1.11

1.5

1.0

—

mmol/l

—

Disorders of other endocrine glands

1.97

1.11

1.0

1.2

—

mmol/l

—

Periodontitis

1.58

1.10

1.2

1.1

—

mmol/l

—

Other bacterial intestinal infections

2.38

1.09

1.0

1.2

—

mmol/l

—

COPD, hospital admissions

1.97

1.09

1.0

1.2

—

mmol/l

—

Obesity related asthma

1.95

1.08

1.0

1.2

—

mmol/l

—

COPD, early/later onset

1.96

1.08

1.0

1.2

—

mmol/l

—

Myocardial infarction, unclassifiable

2.35

1.06

1.4

1.1

—

mmol/l

—

Unspecified haematuria

1.93

1.03

1.0

1.2

—

mmol/l

—

Other neurological diseases

1.68

1.03

1.0

1.2

—

mmol/l

—

L02BG Aromatase inhibitors

2.27

1.03

1.0

1.1

—

Fracture of lumbar spine and pelvis

2.27

1.03

1.0

1.1

—

mmol/l

—

Dyspnoea

1.60

1.03

1.1

—

mmol/l

—

Other arthritis (FG)

2.06

1.02

1.1

—

mmol/l

—

Glaucoma suspect

2.06

1.02

1.3

1.1

—

mmol/l

—

Atopic dermatitis, strict definition with reimbursement

2.05

1.02

1.3

1.2

—

mmol/l

—

Other chronic obstructive pulmonary disease

1.92

1.02

1.0

1.2

—

mmol/l

—

Autoimmune diseases related-to ILD

1.59

1.02

1.1

—

mmol/l

—

Labour and delivery complicated by fetal stress [distress]

2.34

1.02

1.4

1.2

—

mmol/l

—

Other viral diseases

1.99

0.99

1.1

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.01

0.98

1.4

1.3

—

mmol/l

—

Migraine

1.89

0.98

1.1

1.2

—

Complications of medical and surgical care

1.64

0.98

1.1

—

mmol/l

—

Impingement syndrome of shoulder

0.00

0.97

0.0

1.2

—

Pure hypercholesterolaemia

1.84

0.97

1.1

—

mmol/l

—

Asthma, hospital admission 2, infections

1.70

0.96

1.0

1.1

—

mmol/l

—

Asthma-related infections

1.70

0.96

1.0

1.1

—

mmol/l

—

Effects of foreign body entering through natural orifice

1.89

0.94

1.0

1.2

—

mmol/l

—

Urticaria and erythema

1.89

0.94

1.1

1.2

—

mmol/l

—

Disorders of lens

1.64

0.92

1.3

1.1

—

mmol/l

—

Status post-ami

2.18

0.92

1.0

1.2

—

mmol/l

—

Benign lipomatous neoplasm

2.14

0.91

1.2

—

mmol/l

—

Mycoses

2.14

0.91

1.2

—

mmol/l

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.14

0.91

1.0

1.1

—

mmol/l

—

Pulmonary embolism

2.07

0.89

1.0

1.2

—

mmol/l

—

Pulmonary heart disease

2.07

0.89

1.0

1.2

—

mmol/l

—

Oxycodone

1.90

0.88

1.0

1.1

—

mmol/l

—

Other medical care

1.89

0.88

1.0

1.2

—

mmol/l

—

Pacemaker

1.98

0.86

1.0

1.1

—

mmol/l

—

Unstable angina pectoris

1.80

0.85

1.1

—

mmol/l

—

COPD

1.78

0.84

1.0

1.2

—

mmol/l

—

Other/unspecified dorsalgia

1.76

0.83

1.0

1.1

—

mmol/l

—

Psoriasis

1.88

0.81

1.0

1.2

—

mmol/l

—

Other cataract

1.73

0.81

1.1

—

mmol/l

—

1.47

0.81

1.1

—

mmol/l

—

Postmenopausal bleeding

2.43

0.80

1.0

1.1

—

mmol/l

—

Special screening examination for infectious and parasitic diseases

0.00

0.80

0.0

1.1

—

Rotator cuff syndrome

1.66

0.79

1.1

—

mmol/l

—

Seborrhoeic keratosis

0.00

0.79

0.0

1.3

—

Angina pectoris

1.70

0.79

1.1

—

mmol/l

—

Diabetic retinopathy, strict definition

1.83

0.79

1.0

1.2

—

mmol/l

—

Shoulder lesions

1.57

0.79

1.1

—

mmol/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

0.79

0.0

1.2

—

Other/unspecified seropositive rheumatoid arthritis

0.00

0.79

0.0

1.2

—

Seropositive rheumatoid arthritis, wide

0.00

0.79

0.0

1.2

—

Chronic gastritis

0.00

0.79

0.0

1.1

—

Conduction disorders

1.80

0.77

1.0

1.3

—

mmol/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.77

0.0

1.1

—

Tinnitus

0.00

0.77

0.0

1.2

—

Sleep apnoea

1.46

0.76

1.1

—

mmol/l

—

Ischaemic heart disease, wide definition

1.55

0.76

1.2

1.1

—

mmol/l

—

Dorsalgia

1.44

0.76

1.0

1.1

—

mmol/l

—

Voice disturbances

0.00

0.76

0.0

1.3

—

Other viral diseases, not elsewhere classified

1.76

0.75

1.2

1.1

—

mmol/l

—

Candidiasis

2.08

0.74

1.0

1.2

—

mmol/l

—

COPD, hospital admissions 1, only main diagnosis

1.87

0.74

1.0

1.2

—

mmol/l

—

Extrapyramidal and movement disorders

1.84

0.73

1.3

1.2

—

mmol/l

—

Visual disturbances

1.64

0.73

1.0

1.2

—

mmol/l

—

Glaucoma

1.69

0.73

1.3

1.1

—

mmol/l

—

Liquid cancers, helper endpoint

1.80

0.72

1.3

1.2

—

mmol/l

—

Cough

1.79

0.72

1.0

1.1

—

mmol/l

—

Osteopathies and chondropathies

1.63

0.72

1.0

1.1

—

mmol/l

—

malignant neoplasm of male genital organs

1.78

0.72

1.0

1.2

—

mmol/l

—

Visual disturbances and blindness

1.67

0.72

1.0

1.2

—

mmol/l

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.58

0.71

1.0

1.1

—

mmol/l

—

Other diseases of blood and blood-forming organs, wide

1.92

0.70

1.0

1.2

—

mmol/l

—

Other diseases of anus and rectum

1.92

0.70

1.4

1.1

—

mmol/l

—

Dental operations

1.62

0.70

1.2

1.1

—

mmol/l

—

1.65

0.70

1.0

1.2

—

mmol/l

—

Propionic acid derivatives

1.93

0.69

1.0

—

mmol/l

—

Major coronary heart disease event

1.49

0.69

1.2

1.1

—

mmol/l

—

Congenital malformations, deformations and chromosomal abnormalities

1.57

0.69

1.0

1.1

—

mmol/l

—

Sleep apnoea, including avohilmo

1.41

0.67

1.1

—

mmol/l

—

Medicines for HER+ breast cancer

1.82

0.67

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

101

1.44

0.67

1.1

—

mmol/l

—

Complications of procedures, not elsewhere classified

1.48

0.67

1.0

1.1

—

mmol/l

—

Umbilical hernia

1.63

0.66

1.0

1.2

—

mmol/l

—

Gonarthrosis [arthrosis of knee](FG)

1.51

0.64

1.0

1.1

—

mmol/l

—

Asthma (diagnoses ohter than nonallergic)

1.42

0.64

1.0

1.1

—

mmol/l

—

Glucagon-like peptide-1 (GLP-1) analogues

1.72

0.64

1.4

1.2

—

mmol/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1.72

0.64

1.4

1.2

—

mmol/l

—

Chronic periodontitis, including avohilmo

1.40

0.63

1.2

1.1

—

mmol/l

—

Postmenopausal atrophic vaginitis

0.00

0.63

0.0

1.1

—

Cholecystectomy

1.52

0.61

1.1

—

mmol/l

—

Dentofacial anomalies [including malocclusion]

1.49

0.61

1.2

1.1

—

mmol/l

—

Maternal care for other known or suspected fetal problems

0.00

0.60

0.0

1.1

—

Other skin changes

0.00

0.60

0.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.00

0.60

0.0

1.1

—

Benign neoplasm: Sigmoid colon

0.00

0.60

0.0

1.3

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.60

0.0

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

1.48

0.60

1.1

—

mmol/l

—

ILD medications: prednisolone, methylprednisolone, prednisone

1.35

0.60

1.2

1.1

—

mmol/l

—

False labour

1.78

0.59

1.5

1.1

—

ILD medications

1.34

0.59

1.1

—

mmol/l

—

Chronic lower respiratory diseases

1.33

0.59

1.0

1.1

—

mmol/l

—

Endometriosis

1.76

0.59

1.2

1.1

—

mmol/l

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.53

0.58

1.0

1.2

—

mmol/l

—

Diseases of male genital organs

1.46

0.58

1.1

—

mmol/l

—

Certain disorders involving the immune mechanism

0.00

0.58

0.0

1.3

—

Corneal ulcer

0.00

0.58

0.0

1.2

—

Seropositive rheumatoid arthritis

0.00

0.58

0.0

1.2

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.62

0.55

1.5

1.0

—

mmol/l

—

Diseases of external ear

1.62

0.55

1.0

1.2

—

Obesity, other/unspecified

1.62

0.55

1.0

1.2

—

mmol/l

—

Diabetic retinopathy

1.52

0.55

1.1

1.2

—

mmol/l

—

Asthma, including avohilmo

1.32

0.54

1.1

—

mmol/l

—

Diaphragmatic hernia

1.58

0.54

1.3

1.2

—

mmol/l

—

Hypothyroidism, strict autoimmune

1.45

0.53

1.1

—

mmol/l

—

Venous thromboembolism

1.45

0.53

1.1

—

mmol/l

—

Lower back pain or/and sciatica

1.33

0.52

1.1

—

mmol/l

—

Retinal detachments and breaks

1.50

0.51

1.0

1.2

—

mmol/l

—

Other disorders of skin and subcutaneous tissue

1.44

0.50

1.0

1.1

—

mmol/l

—

Cholelithiasis

1.42

0.49

1.1

—

mmol/l

—

DVT of lower extremities and pulmonary embolism

1.55

0.48

1.0

1.2

—

mmol/l

—

Gonarthrosis,primary

1.38

0.48

1.0

1.1

—

mmol/l

—

Fracture of forearm

1.48

0.47

1.0

1.1

—

mmol/l

—

Heart failure and coronary heart disease

1.46

0.47

1.0

1.1

—

mmol/l

—

Peripheral artery disease

1.43

0.46

1.0

1.2

—

Acute upper respiratory infections

1.32

0.45

1.1

—

mmol/l

—

Cholelithiasis, broad definition with cholecystitis

1.39

0.44

1.1

—

mmol/l

—

Examination and observation for other reasons

1.45

0.44

1.2

1.0

—

mmol/l

—

Any dementia

1.65

0.44

1.4

1.0

—

mmol/l

—

Diseases of the musculoskeletal system and connective tissue

1.45

0.44

1.2

1.1

—

mmol/l

—

Sulfonylureas

1.66

0.43

1.0

1.2

—

mmol/l

—

Other specified/unspecified arthritis

1.61

0.43

1.2

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.61

0.43

1.0

1.2

—

mmol/l

—

Malignant neoplasm of breast, HER-positive

1.56

0.42

1.0

1.1

—

Appendectomy

0.64

0.42

1.2

1.1

—

mmol/l

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.56

0.42

1.4

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1.54

0.42

1.0

1.1

—

Perineal laceration during delivery

0.00

0.41

0.0

1.2

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.41

0.0

1.1

—

Alzheimer’s disease (Late onset)

0.00

0.41

0.0

1.1

—

Inguinal or femoral hernia, bilateral

0.00

0.41

0.0

1.1

—

Sarcoidosis

0.00

0.41

0.0

1.2

—

Other inflammation of eyelid

0.00

0.41

0.0

1.2

—

Endometriosis ASRM stages 1,2

0.00

0.41

0.0

1.3

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.41

0.0

1.2

—

Malignant neoplasm of breast, HER-negative

0.00

0.41

0.0

1.2

—

Prolonged pregnancy

0.00

0.41

0.0

1.1

—

Oral corticosteroids

1.28

0.41

1.2

1.1

—

mmol/l

—

Reimbursement for rheumatic diseases

1.42

0.41

1.3

1.1

—

mmol/l

—

Malignant melanoma, including Hilmo

0.00

0.40

0.0

1.2

—

Medical observation and evaluation for suspected diseases and conditions

1.39

0.40

1.0

—

mmol/l

—

Endometriosis of pelvic peritoneum

0.00

0.40

0.0

1.1

—

Maternal care for known or suspected malpresentation of fetus

0.00

0.40

0.0

1.1

—

Chondropathies

0.00

0.40

0.0

1.3

—

Lichen planus, including avohilmo

0.00

0.40

0.0

1.2

—

Transient ischemic attack

1.32

0.40

1.0

1.2

—

mmol/l

—

Arthropathies

1.30

0.39

1.2

1.1

—

mmol/l

—

Use of other anti-dementia drugs

0.00

0.39

0.0

1.1

—

Use of memantine

0.00

0.39

0.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.34

0.39

1.2

1.1

—

mmol/l

—

Triptan medication for migraine, single purchase ok

1.34

0.39

1.2

1.1

—

mmol/l

—

Other disorders of lacrimal gland

1.43

0.39

1.0

1.2

—

mmol/l

—

Asthma, hospital admissions , main diagnosis only

101

1.31

0.39

1.0

1.1

—

mmol/l

—

Presence of other devices

0.00

0.39

0.0

1.1

—

Atopic dermatitis, strict definition

1.40

0.38

1.4

1.1

—

mmol/l

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.38

0.38

1.3

1.0

—

mmol/l

—

Sulfasalazine

1.39

0.38

1.4

1.2

—

mmol/l

—

Ischaemic Stroke, excluding all haemorrhages

1.34

0.38

1.1

1.2

—

mmol/l

—

Acute sinusitis

1.34

0.38

1.0

1.1

—

mmol/l

—

Other arrhythmias

1.40

0.36

1.2

—

mmol/l

—

Caries of enamel

0.74

0.36

1.0

1.1

—

mmol/l

—

Cardiodefibrillation

1.46

0.36

1.0

1.1

—

mmol/l

—

Tonsillectomy and adenotomy

1.37

0.35

1.1

—

mmol/l

—

Disorders of lacrimal system

1.36

0.34

1.0

1.2

—

mmol/l

—

Cervical disc disorders

1.28

0.32

1.3

1.1

—

mmol/l

—

Other viral diseases

1.31

0.30

1.1

1.2

—

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of knee

1.32

0.30

1.0

1.1

—

mmol/l

—

Coronary atherosclerosis

1.35

0.29

1.0

1.1

—

mmol/l

—

Malignant neoplasm, wide definition for exclusion

1.26

0.29

1.1

—

mmol/l

—

Asthma/COPD (KELA code 203)

1.23

0.28

1.1

—

mmol/l

—

Pain in joint

1.24

0.27

1.0

1.1

—

mmol/l

—

Benign neoplasm: Colon

1.23

0.27

1.3

1.1

—

mmol/l

—

Gonarthrosis, primary, with knee surgery

1.20

0.26

1.0

1.2

—

mmol/l

—

Diseases of oral cavity, salivary glands and jaws

1.25

0.26

1.1

—

Coxarthrosis, primary

0.68

0.26

1.0

1.1

—

mmol/l

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.68

0.26

1.0

1.2

—

mmol/l

—

Senile cataract

1.30

0.25

1.3

1.1

—

mmol/l

—

Diverticular disease of intestine

0.71

0.24

1.2

1.1

—

mmol/l

—

Nerve, nerve root and plexus disorders

1.20

0.24

1.1

—

mmol/l

—

Solid cancers, helper endpoint

1.23

0.24

1.0

1.1

—

mmol/l

—

Excessive attrition of teeth

1.28

0.24

1.3

1.1

—

mmol/l

—

Dermatophytosis

0.71

0.24

1.0

1.1

—

mmol/l

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1.28

0.23

1.0

1.1

—

mmol/l

—

1.24

0.22

1.0

1.1

—

mmol/l

—

Malignant neoplasm of digestive organs

1.20

0.21

1.0

1.2

—

mmol/l

—

Arthrosis

1.24

0.21

1.0

1.1

—

mmol/l

—

Dementia, including avohilmo

1.19

0.21

1.6

1.0

—

mmol/l

—

Other Crohn's disease

0.00

0.21

0.0

1.1

—

Spermatocele

0.00

0.21

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.1

—

Other and/or unspecified nontoxic goitre

0.00

0.21

0.0

1.2

—

Other congenital malformations of skin

0.00

0.21

0.0

1.1

—

Acne vulgaris

0.00

0.21

0.0

1.1

—

Stenosis and insufficiency of lacrimal passages

0.00

0.21

0.0

1.1

—

Overexertion and strenuous or repetitive movements

0.00

0.21

0.0

1.1

—

Malignant melanoma of skin

0.00

0.21

0.0

1.1

—

Benign neoplasm of breast

0.00

0.21

0.0

1.3

—

Pain associated with micturition

0.00

0.21

0.0

1.1

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.3

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.2

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.21

0.0

1.0

—

Fenamates

0.00

0.21

0.0

1.0

—

Special screening examination for neoplasms

0.00

0.21

0.0

1.2

—

Eustachian salpingitis and obstruction

0.00

0.21

0.0

1.1

—

Other and unspecified rosacea

0.00

0.21

0.0

1.3

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.2

—

Herpesviral [herpes simplex] infections

0.00

0.21

0.0

1.2

—

Melanocytic naevi of trunk

0.00

0.21

0.0

1.2

—

Mixed conductive and sensorineural hearing loss

0.00

0.21

0.0

1.2

—

Crohn disease

0.00

0.21

0.0

1.2

—

Parkinson's disease, strict definition

0.00

0.21

0.0

1.2

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.2

—

Unspecified lump in breast

0.00

0.21

0.0

1.3

—

Malignant neoplasm of colon

0.00

0.21

0.0

1.0

—

Other congenital malformations

0.00

0.21

0.0

1.2

—

Other diseases of lip and oral mucosa

1.16

0.21

1.2

1.1

—

Gingivitis and periodontal diseases

0.83

0.21

1.2

1.1

—

mmol/l

—

Diseases of the ear and mastoid process

1.17

0.21

1.1

—

mmol/l

—

Graves disease, strict definition

0.00

0.21

0.0

1.2

—

Lichen planus

0.00

0.21

0.0

1.2

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

0.00

0.21

0.0

1.2

—

Other metabolic disorders

0.00

0.21

0.0

1.2

—

Allergic contact dermatitis

0.00

0.21

0.0

1.2

—

Malignant melanoma of skin, including Hilmo

0.00

0.21

0.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

1.2

—

Acne

0.00

0.21

0.0

1.1

—

Persons encountering health services for examination and investigation

1.25

0.20

1.3

1.0

—

mmol/l

—

Other disorders of amniotic fluid and membranes

0.00

0.20

0.0

1.2

—

Presence of cardiac and vascular implants and grafts

1.27

0.20

1.0

1.1

—

mmol/l

—

Irregular menses

1.28

0.20

1.5

1.1

—

mmol/l

—

Other intervertebral disc disorders

0.77

0.20

1.2

1.1

—

mmol/l

—

Other joint disorders

1.20

0.20

1.2

1.1

—

mmol/l

—

Disorders of conjunctiva

0.81

0.20

1.0

1.1

—

mmol/l

—

Temporomandibular joint disorders, including avohilmo

1.26

0.20

1.3

1.1

—

mmol/l

—

Rosacea

0.00

0.20

0.0

1.2

—

Thyroiditis, ILD-related definition

0.00

0.20

0.0

1.2

—

Inguinal hernia, bilateral

0.00

0.20

0.0

1.1

—

Malignant melanoma

0.00

0.20

0.0

1.1

—

Radiculopathy

0.00

0.20

0.0

1.4

—

Recurrent aphthous stomatitis , including avohilmo

0.00

0.20

0.0

1.1

—

L02BA Anti-estrogens

0.00

0.20

0.0

1.2

—

Malignant neoplasm of colon, including Hilmo

0.00

0.20

0.0

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.21

0.20

1.0

1.2

—

mmol/l

—

Papulosquamous disorders

1.22

0.20

1.0

1.2

—

mmol/l

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1.24

0.19

1.1

—

mmol/l

—

Zoster [herpes zoster]

1.16

0.19

1.2

1.1

—

mmol/l

—

Inflammatory bowel disease treatment related agents

1.15

0.19

1.2

1.1

—

mmol/l

—

Percutaneous Coronary Intervention

1.21

0.17

1.0

1.1

—

mmol/l

—

Coronary revascularization (ANGIO or CABG)

1.20

0.17

1.0

1.1

—

mmol/l

—

Malignant neoplasm

1.18

0.17

1.1

—

mmol/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.13

0.17

1.0

1.2

—

mmol/l

—

Disease of hard tissues of teeth, NOS

1.16

0.17

1.5

1.1

—

mmol/l

—

Spondylosis

1.16

0.16

1.0

1.1

—

mmol/l

—

Other diseases of hard tissues of teeth

1.12

0.16

1.5

1.1

—

mmol/l

—

Meniscus derangement

0.79

0.16

1.2

1.1

—

mmol/l

—

Chronic periodontitis, complicated

1.10

0.15

1.4

1.1

—

mmol/l

—

Disorders of sclera, cornea, iris and ciliary body

1.10

0.15

1.4

1.1

—

mmol/l

—

L04AX Other immunosuppressants

1.15

0.15

1.0

1.1

—

mmol/l

—

Second line medication for Crohn's disease

1.14

0.15

1.0

1.1

—

mmol/l

—

Other specific joint derangements/joint disorders

1.17

0.14

1.0

1.1

—

mmol/l

—

Conjunctivitis

0.84

0.13

1.0

1.1

—

mmol/l

—

Chronic diseases of tonsils and adenoids

1.15

0.13

1.1

—

mmol/l

—

First line medication for Crohn's disease

1.12

0.12

1.3

1.1

—

mmol/l

—

Disorders of the thyroid gland

0.88

0.11

1.1

—

mmol/l

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.16

0.10

1.0

1.2

—

Malignant neoplasm of breast, including Hilmo

1.16

0.10

1.0

1.2

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.13

0.10

1.0

1.2

—

mmol/l

—

Degeneration of macula and posterior pole

1.08

0.09

1.0

1.1

—

mmol/l

—

Glucosamine medication

1.05

0.09

1.0

1.1

—

mmol/l

—

Pregnancy with abortive outcome

1.12

0.09

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.10

0.09

1.0

1.2

—

mmol/l

—

Striking against or struck by other objects

1.09

0.08

1.0

1.1

—

mmol/l

—

Malignant neoplasm of skin

1.05

0.08

1.0

1.2

—

mmol/l

—

Follow-up examination after treatment for conditions other than malignant neoplasms

1.04

0.08

1.5

1.1

—

mmol/l

—

Hyperplasia of prostate

1.03

0.08

1.0

1.1

—

mmol/l

—

Disorders of eyelid, lacrimal system and orbit

0.88

0.08

1.0

1.1

—

mmol/l

—

Coxarthrosis [arthrosis of hip](FG)

0.76

0.08

1.0

1.1

—

mmol/l

—

Diseases of inner ear

0.77

0.08

1.0

1.1

—

mmol/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.09

0.08

1.3

1.1

—

Inguinal hernia

1.13

0.08

1.2

1.1

—

mmol/l

—

Allergic conjunctivitis

1.08

0.08

1.0

1.1

—

mmol/l

—

Sciatica+with lumbago

1.07

0.08

1.1

—

mmol/l

—

Emergency coronary revascularization (for ACS)

1.11

0.07

1.0

1.1

—

mmol/l

—

Excessive earwax

0.85

0.07

1.0

1.1

—

mmol/l

—

Dorsopathies

1.09

0.07

1.1

—

mmol/l

—

Atopic dermatitis

1.07

0.07

1.3

1.1

—

mmol/l

—

Benign neoplasm of colon, rectum, anus and anal canal

1.04

0.07

1.3

1.1

—

mmol/l

—

Gonarthrosis

1.05

0.07

1.0

1.1

—

mmol/l

—

Diseases of arteries, arterioles and capillaries

1.02

0.07

1.0

1.1

—

mmol/l

—

Acute appendicitis, no complications

0.87

0.06

1.4

1.1

—

mmol/l

—

Hypothyroidism, other/unspecified

1.08

0.05

1.1

—

mmol/l

—

Diseases of appendix

0.91

0.05

1.4

1.1

—

mmol/l

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.08

0.04

1.1

—

mmol/l

—

Appendicitis, broad definition

0.91

0.04

1.4

1.1

—

mmol/l

—

Benign neoplasms

1.06

0.04

1.2

1.1

—

mmol/l

—

ILD medications: immunosuppressive drugs

1.08

0.02

1.2

1.1

—

mmol/l

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.07

0.02

1.1

—

mmol/l

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.95

0.02

1.2

1.1

—

mmol/l

—

Mycoses

108

0.97

0.00

1.1

—

mmol/l

—

Other dorsopathies, not elsewhere classified

1.01

0.00

1.3

1.1

—

mmol/l

—

Acute appendicitis

0.96

0.00

1.4

1.1

—

mmol/l

—

Neoplasms

1.04

0.00

1.3

1.1

—

mmol/l

—

Conductive and sensorineural hearing loss

0.95

0.00

1.2

1.1

—

mmol/l

—

Sensorineural hearing loss

1.00

0.00

1.2

1.1

—

mmol/l

—

Artrosis, including avohilmo

0.98

0.00

1.2

1.1

—

mmol/l

—

Artificial joint operation, meniscal resection

0.99

0.00

1.1

—

mmol/l

—

Any event in cancer register

1.03

0.00

1.2

1.1

—

mmol/l

—

Other disorders of ear

1.03

0.00

1.2

1.1

—

mmol/l

—

Melanocytic naevi, other sites/unspecified

0.00

0.0

1.1

—

Other diseases of arteries and capillaries

0.00

0.0

1.0

—

Foreign body entering into or through eye or natural orifice

0.00

0.0

1.0

—

Excessive vomiting in pregnancy

0.00

0.0

1.1

—

Thyroiditis

0.00

0.0

1.2

—

Pustular psoriasis

0.00

0.0

1.0

—

Asthma and allergy, excluding more controls

0.00

0.0

1.5

—

Need for other prophylactic measures

0.00

0.0

1.0

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

0.00

0.0

1.1

—

Other disorders of pigmentation

0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

0.0

1.0

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.0

1.2

—

Ovarian dysfunction

0.00

0.0

1.3

—

Other and unspecified coagulation defects

0.00

0.0

1.1

—

Golimumab

0.00

0.0

1.0

—

Cardiac murmurs and other cardiac sounds

0.00

0.0

1.0

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.0

1.1

—

Carcinoma in situ of cervix uteri

0.00

0.0

1.3

—

Left bundle-branch block

0.00

0.0

1.3

—

Other congenital malformations

0.00

0.0

1.1

—

Chronic suppurative otitis media, including avohilmo

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.3

—

Crohn's disease of small intestine

0.00

0.0

1.1

—

Inflammatory disease of cervix uteri

0.00

0.0

1.2

—

Polycystic ovarian syndrome

0.00

0.0

1.2

—

Inflammatory diseases of female pelvic organs

0.92

0.00

1.2

1.1

—

mmol/l

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.0

1.1

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.0

—

Sicca syndrome [Sjögren]

0.00

0.0

1.1

—

Other infective otitis externa

0.00

0.0

1.0

—

Benign neoplasm: Descending colon

0.00

-0.00

0.0

1.0

—

Disorders resulting from impaired renal tubular function

0.00

-0.00

0.0

1.0

—

Colon adenocarcinoma

0.00

-0.00

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Corns and callosities

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of cervix uteri

0.00

-0.00

0.0

1.1

—

Other coagulation defects

0.00

-0.00

0.0

1.1

—

Mandibular retrognathia

0.00

-0.00

0.0

1.0

—

Other specified and unspecified retinal disorders

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

1.3

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Lumbar disc prolapse

0.89

-0.00

1.3

1.1

—

mmol/l

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome, consortium definition

1.01

-0.00

1.4

1.0

—

mmol/l

—

Vasomotor rhinitis (mode)

0.00

-0.00

0.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.3

—

Other necrotizing vasculopathies (FG)

0.00

-0.00

0.0

1.0

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

1.1

—

Impacted maxillary molar

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of thorax

0.00

-0.00

0.0

1.0

—

Crohn's disease NAS

0.00

-0.00

0.0

1.1

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.0

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Crohn's disease of large intestine

0.00

-0.00

0.0

1.2

—

Other and unspecified mononeuropathies of upper limb

0.00

-0.00

0.0

1.0

—

Hypopituitarism

0.00

-0.00

0.0

1.1

—

Pathological resorption of teeth

0.00

-0.00

0.0

1.0

—

Other erythematous conditions

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

1.0

—

Memory loss

0.00

-0.00

0.0

1.0

—

Non-rheumatic valve diseases

0.97

-0.00

1.0

1.2

—

mmol/l

—

Other disorders involving the immune mechanism, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, all UC cases excluded)

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of thyroid gland, including Hilmo

0.00

-0.00

0.0

1.2

—

Kidney transplant status

0.00

-0.00

0.0

1.0

—

Anisometropia and aniseikonia

0.00

-0.00

0.0

1.0

—

Scleritis and episcleritis

0.00

-0.00

0.0

1.1

—

Pleural plaque with presence of asbestos

0.00

-0.00

0.0

1.3

—

Vertical strabismus

0.00

-0.00

0.0

1.0

—

Carpal tunnel syndrome

0.89

-0.00

1.1

—

mmol/l

—

Ulcerative rectosigmoiditis

0.00

-0.00

0.0

1.1

—

Raynaud syndrome

0.00

-0.00

0.0

1.1

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

-0.00

0.0

1.4

—

Thyrotoxicosis with toxic multinodular goitre

0.00

-0.00

0.0

1.0

—

Female infertility, associated with anovulation

0.00

-0.00

0.0

1.1

—

Herpesviral keratitis and keratoconjunctivitis

0.00

-0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

1.2

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

0.00

-0.00

0.0

1.2

—

Other obstetric trauma

0.00

-0.00

0.0

1.5

—

Transient global amnesia

0.00

-0.00

0.0

1.0

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

1.3

—

Other peripheral vascular diseases

0.00

-0.00

0.0

1.1

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

-0.00

0.0

1.0

—

Chronic iridocyclitis

0.00

-0.00

0.0

1.0

—

Hypermetropia

0.00

-0.00

0.0

1.0

—

Other noninflammatory disorders of vagina

0.00

-0.00

0.0

1.1

—

Demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.2

—

Spinal stenosis

0.86

-0.00

1.0

1.2

—

mmol/l

—

Congenital malformations of eye, ear, face and neck

0.00

-0.00

0.0

1.0

—

Normotensive glaucoma

0.00

-0.00

0.0

1.0

—

Crohn disease (strict definition, require KELA)

0.00

-0.00

0.0

1.1

—

Chronic suppurative otitis media

0.00

-0.00

0.0

1.0

—

Cluster headache, strict, including avohilmo

0.00

-0.00

0.0

1.2

—

Dermatographic urticaria

0.00

-0.00

0.0

1.1

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

Varicose veins of other sites

0.00

-0.00

0.0

1.0

—

Juvenile osteochondrosis

0.00

-0.00

0.0

1.0

—

Mouth breathing

0.95

-0.00

1.0

1.1

—

mmol/l

—

Cluster headache, wide,, including avohilmo

0.00

-0.00

0.0

1.2

—

Female infertility, tubal origin

0.00

-0.00

0.0

1.2

—

Pneumothorax

0.00

-0.00

0.0

1.0

—

Other disorders of nervous system

0.00

-0.00

0.0

1.0

—

Cardiomyopathy, other and unspecified

0.00

-0.00

0.0

1.3

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

-0.00

0.0

1.0

—

Oral lichen planus, including avohilmo , including avohilmo

0.00

-0.00

0.0

1.0

—

Other necrotizing vasculopathies

0.00

-0.00

0.0

1.0

—

Coxarthrosis

0.85

-0.00

1.0

1.1

—

mmol/l

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.0

—

Immunodeficiencies

0.00

-0.00

0.0

1.0

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.2

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.00

-0.00

0.0

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

-0.00

0.0

1.1

—

Autoimmune hyperthyroidism

0.00

-0.00

0.0

1.3

—

Malignant neoplasm of thyroid gland

0.00

-0.00

0.0

1.2

—

Other and unspecified disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of ovary, including Hilmo

0.00

-0.00

0.0

1.2

—

Pleural plaque

0.00

-0.00

0.0

1.3

—

Ptosis of eyelid

0.00

-0.00

0.0

1.0

—

Unspecified urinary incontinence

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at hip and thigh level

0.00

-0.00

0.0

1.3

—

Abnormal findings on diagnostic imaging of lung

0.87

-0.00

1.0

1.1

—

mmol/l

—

Disorders of thyroid, IBD co-morbidities

0.00

-0.00

0.0

1.0

—

Other abnormal findings of blood chemistry

0.00

-0.00

0.0

1.0

—

Triptan medication for migraine, min. 3 purchases

0.97

-0.00

1.4

1.1

—

mmol/l

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Other maternal disorders predominantly related to pregnancy

0.90

-0.00

1.2

1.1

—

mmol/l

—

Benign neoplasm: Parotid gland

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

-0.00

0.0

1.4

—

Fall on and from ladder

0.00

-0.00

0.0

1.0

—

Extracorporeal dialysis

0.00

-0.00

0.0

1.0

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

1.0

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Mixed connective tissue disease

0.00

-0.00

0.0

1.2

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

-0.00

0.0

1.1

—

Pustulosis palmaris et plantaris

0.00

-0.00

0.0

1.0

—

Multiple delivery

0.00

-0.00

0.0

1.1

—

Desensitization to allergens

0.00

-0.00

0.0

1.1

—

Pedestrian injured in collision with pedal cycle

0.00

-0.00

0.0

1.0

—

Preparatory care for dialysis

0.00

-0.00

0.0

1.0

—

Other dialysis

0.00

-0.00

0.0

1.0

—

Total colectomy

0.00

-0.00

0.0

1.0

—

Certain conditions originating in the perinatal period

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Stomach

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin

0.00

-0.00

0.0

1.0

—

Artificial joint re-operation

0.00

-0.00

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

-0.00

0.0

1.4

—

Total colectomy operation

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.4

—

Dermatitis

0.92

-0.00

1.0

1.1

—

mmol/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.3

—

0.00

-0.00

0.0

1.3

—

Vulvovaginal ulceration/inflammation in other diseases

0.00

-0.00

0.0

1.2

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ethylene glycol [Moles/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS